Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Mentholatum ibuprofen gel versus Ibuleve ibuprofen gel
NL-OMON51126Completed
- Sponsor
- Mentholatum
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ibuprofen in pain and inflammation (2 arms), sponsored by Mentholatum. Primary endpoints: AUC0-t of (RS) ibuprofen, Cmax of (RS) ibuprofen and 1 more. Started Feb 2021; status: completed.
02
Drugs
ibuprofen
03
Conditions
paininflammation
Beyond the preview
Go deeper on NL-OMON51126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51126.